SEC Form D · filed October 18, 2018
INNOVATE BIOPHARMACEUTICALS, INC
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (20)
Lorin Johnson · Raleigh, NCDirectorJay Madan · Raleigh, NCExec · DirectorRoy Proujansky · Raleigh, NCDirectorSandeep Laumas · Raleigh, NCExec · DirectorAnthony Maida · Raleigh, NCDirectorChristopher Prior · Raleigh, NCExec · DirectorSaira Ramasastry · Raleigh, NCDirectorChristine Tsai · San Francisco, CADirectorSanjay Anand · Los Angeles, CAExec · DirectorTodd R. Tarbert · BELLEVUE, WADirectorJeong Min Lim · San Francisco, CADirectorHui Chen · New York, NYExec · DirectorVictor Gajendran · Los Angeles, CAExec · DirectorDr. Melissa K. Rhodes · San Francisco, CADirectorKerry Faix · West Chester, PADirectorSteven Lloyd · West Chester, PAExec · DirectorJonas Pilkauskas · SAN FRANCISCO, CADirectorRomas Matiukas · SAN FRANCISCO, CAExec · DirectorKeith S. Greenfield · Boston, MAExec · DirectorSaira Ramasastry · Austin, TXDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗